Journal of Cardiac Failure
Volume 14, Issue 8 , Pages 695-702 , October 2008

Alveolar Gas Diffusion Abnormalities in Heart Failure

  • Marco Guazzi, MD, PHD, FACC

      Affiliations

    • Corresponding Author InformationReprint requests: Marco Guazzi, MD, PhD, FACC, University of Milano, Cardiology Division, San Paolo Hospital, Via A. di Rudinì, 8, 20142 Milano, Italy.

Received 26 January 2008 ,Revised 2 May 2008 ,Accepted 2 June 2008.

References 

  1. Guazzi M. Alveolar-capillary membrane dysfunction in heart failure. Evidence of a pathophysiological role. Chest. 2003;124:1090–1102
  2. Ghandi SK, Powers JC, Nomeir AM, Fowle K, Kitzman DW, Rankim KM, et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med. 2001;344:17–22
  3. West JB. Cellular responses to mechanical stress. Invited review: pulmonary-capillary stress failure. J Appl Physiol. 2000;89:2483–2489
  4. Saldias FJ, Azzam ZS, Ridge M, Yeldandi A, Rutshman DH, Schraufnagel D, et al. Alveolar fluid reabsorption is impaired by increased left atrial pressure in rats. Am J Physiol. 2001;281:L591–L597
  5. Mathieu-Costello O, Willford DC, Fu Z, Garden RM, West JB. Pulmonary capillaries are more resistant to stress failure in dogs than in rabbits. J Appl Physiol. 1995;79:908–917
  6. Conforti E, Fenoglio C, Bernocchi G, Bruschi O, Miserocchi GA. Morpho-functional analysis of lung tissue in mild interstitial edema. Am J Physiol. 2002;282:L766–L774
  7. Negrini D, Passi A, De Luca G, Miserocchi G. Pulmonary interstitial pressure and proteoglycans during development of pulmonary edema. Am J Physiol. 1996;270:H2000–H2007
  8. Palestini P, Calvi E, Conforti L, Botto C, Fenoglio G, Miserocchi G. Composition, biophysical properties and morphometry of plasma membranes in pulmonary interstitial edema. Am J Physiol. 2002;282:L1382–L1390
  9. De Pasquale C, Arnolda LF, Doyle IR, Grant RL, Aylward PA, Bernsten AD. Prolonged alveolar capillary barrier damage after acute cardiogenic pulmonary edema. Crit Care. 2003;31:1060–1067
  10. Guazzi M, Arena R, Guazzi MD. Evolving changes in lung interstitial fluid content after acute myocardial infarction: mechanisms and pathophysiological correlates. Am J Physiol Heart Circ Physiol. 2008;294:H1357–H1364
  11. Guazzi M, Agostoni P, Busotti M, Guazzi MD. Impeded alveolar-capillary gas transfer with saline infusion in heart failure. Hypertension. 1999;34:1202–1207
  12. Levi BD, Shapiro SD. Acute respiratory distress syndrome. In:  Kasper DL,  Braunwald E,  Fauci AS,  Hauser SL,  Longo DL,  Jameson JL editor. Principles of internal medicine. 16th edition. New York: McGraw-Hill; 2005;p. 1731–1736
  13. Huchon GJ, Hopewell PC, Murray JF. Interactions between permeability and hydrostatic pressure in perfused dogs lungs. J Appl Physiol. 1981;50:905–911
  14. Bland RD. Lung epithelial ion transport and fluid movement during perinatal period. Am J Physiol. 1990;259:L30–L37
  15. Basset G, Crone C, Saumon G. Fluid absorption by rat lung in situ: pathways for sodium entry in the luminal membrane of alveolar epithelium. J Physiol. 1987;384:325–345
  16. Matthay MA, Folkesson HG, Verkman AS. Salt and water transport across alveolar and distal airway epithelia in the adult lung. Am J Physiol. 1996;270:L487–L503
  17. Matalon S, O'Brodovich H. Sodium channels in alveolar epithelial cells: molecular characterization, biophysical properties, physiological significance. Annu Rev Physiol. 1999;61:627–661
  18. Goodman BE, Kim KJ, Crandall ED. Evidence for active sodium transport across alveolar epithelium of isolated rat lung. J Appl Physiol. 1987;62:2460–2466
  19. Harris P, Heath D. The human pulmonary circulation. Its form and function in health and disease. 2nd edition. London: Churchill Livingstone; 1977;
  20. Hughes JMB. The lungs in heart disease. In:  Murray JF,  Nadel JA editor. Textbook of respiratory medicine. 2nd edition. London: WB Saunders Co; 1994;p. 2200–2222
  21. Factor P, Saldias F, Ridge K, Dumasius V, Zabner J, Jaffe HA, et al. Augmentation of liquid clearance via adenovirus-mediated transfer of Na+-K+ATPase β1 subunit gene. J Clin Invest. 1998;102:1421–1430
  22. Azzam ZS, Dumasius V, Saldias FJ, Adir Y, Sznaider JL, Factor P. Na, K-ATPase overexpression improves alveolar fluid clearance in a rat model of elevated left atrial pressure. Circulation. 2002;105:497–501
  23. Suzuki S, Noda M, Sugta M, Ono S, Koike K, Fujimura S. Impairment of transalveolar fluid transport and lung Na+-K+ATPase function by hypoxia in rats. J Appl Physiol. 1999;87:962–968
  24. Elliott AR, Fu Z, Tsukimoto K, Prediletto R, Elliott AR, Mathieu-Costello O, et al. Short-term reversibility of ultrastructural changes in pulmonary capillaries caused by stress failure. J Appl Physiol. 1992;73:1150–1158
  25. Tomsley MI, Fu Z, Mathieu-Costello O, West JB. Pulmonary microvascular permeability: responses to high vascular pressure after induction of pacing induced heart failure in dogs. Circ Res. 1995;77:317–325
  26. Lee JS. Electron microscopic studies on the alveolar-capillary barrier in patients with chronic pulmonary edema. Jpn Circ J. 1979;43:945–954
  27. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardization of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26:720–735
  28. Roughton FJW, Forster FE. Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in human lung, with special reference to true diffusing capacity of blood in the lung capillary. J Appl Physiol. 1957;11:290–302
  29. Al Rawas OA, Carter R, Stevenson RD, Naik SK, Wheatley DJ. Exercise intolerance following heart transplantation: the role of pulmonary diffusing capacity impairment. Chest. 2000;118:1661–1670
  30. Puri S, Backer L, Dukta DP, Oakley C, Hughes JMB, Cleland JGF. Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance. Circulation. 1995;91:2769–2774
  31. Wright RS, Levine MS, Bellamy PE, Simmons MS, Batra P, Stevenson LW, et al. Ventilatory and diffusion capacity in potential heart transplant recipients. Chest. 1990;98:816–820
  32. Davies SW, Bailey J, Keegan J, Balcon R, Rudd RM, Lipkin DP. Reduced pulmonary microvascular permeability in severe chronic left heart failure. Am Heart J. 1992;124:137–142
  33. Siegel JL, Miller A, Brown LK, De Luca A, Teirstein AS. Pulmonary diffusion capacity in left ventricular dysfunction. Chest. 1990;8:550–553
  34. Naum C, Sciurba FC, Rogers MB. Pulmonary function abnormalities in chronic severe cardiomyopathy preceding cardiac transplantation. Am Rev Respir Dis. 1992;145:1334–1338
  35. Ravenscraft SA, Gross CR, Kubo SH. Pulmonary function after successful heart transplantation. Chest. 1993;103:54–55
  36. Ohar J, Osterloh J, Ahmed N, Miller L. Diffusing capacity decreases after heart transplantation. Chest. 1993;103:857–861
  37. Kraemer MD, Kubo SH, Rector TS, Brunsvold N, Bank AJ. Pulmonary and peripheral vascular factors are important determinants of peak exercise oxygen uptake in patients with heart failure. J Am Coll Cardiol. 1993;21:641–648
  38. Messner-Pellenc P, Brasiliero C, Ahmadi S, Mercier J, Ximenes C, Grolleau R, et al. Exercise intolerance in patients with chronic heart failure: role of pulmonary diffusing limitation. Eur Heart J. 1995;16:201–209
  39. Guazzi M, Marenzi G, Alimento M, Contini M, Guazzi MD. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation. 1997;95:1930–1936
  40. Assayag P, Benamer H, Aubry P, de Picciotto C, Brochet E, Besse S. Alteration of the alveolar-capillary membrane diffusing capacity in chronic left heart disease. Am J Cardiol. 1998;82:459–464
  41. Puri S, Dutka DP, Baker BL, Hughes JM, Cleland JG. Acute saline infusion reduces alveolar-capillary membrane conductance and increases airflow obstruction in patients with left ventricular dysfunction. Circulation. 1999;99:1190–1196
  42. Guazzi M, Brambilla R, Pontone G, Agostoni P, Guazzi MD. Effect of non-insulin-dependent diabetes mellitus on pulmonary function and exercise tolerance in chronic congestive heart failure. Am J Cardiol. 2002;89:191–197
  43. Abraham MR, Olsen LJ, Joyner MJ, Turner ST, Beck KC, Johnson BD. Angiotensin-converting enzyme genotype modulates pulmonary function and exercise capacity in treated patients with congestive stable heart failure. Circulation. 2002;106:1794–1799
  44. Agostoni P, Bussotti M, Cattadori G, Margutti E, Contini M, Muratori M, et al. Gas diffusion and alveolar-capillary unit in chronic heart failure. Eur Heart J. 2006;27:2538–2543
  45. Matthay MA, Folkesson HG, Verkman AS. Salt and water transport across alveolar and distal airway epithelia in the adult lung. Am J Physiol. 1996;270:L487–L503
  46. Kraemer MD, Kubo SH, Rector TS, Brunsvold M, Bank AJ. Pulmonary and peripheral vascular factors are important determinants of peak exercise oxygen uptake in patients with heart failure. J Am Coll Cardiol. 1993;21:641–648
  47. Smith AA, Cowbum PJ, Parker ME. Impaired pulmonary diffusion during exercise in patients with chronic heart failure. Circulation. 1999;100:1406–1410
  48. Guazzi M, Reina G, Tumminello G, Guazzi MD. Alveolar-capillary membrane conductance is the best pulmonary correlate of exercise ventilatory efficiency in heart failure patients. Eur J Heart Fail. 2005;7:1017–1022
  49. Johnson BD, Beck KC, Olson LY, O'Malley KA, Allison TG, Squires RW, et al. Ventilation constraints during exercise in patients with chronic heart failure. Chest. 2000;117:321–332
  50. Hsia CCW. Recruitment of lung diffusing capacity: update of concept and application. Chest. 2002;122:1774–1783
  51. Agostoni PG, Cattadori G, Bianchi M, Wasserman K. Exercise induced pulmonary edema in heart failure. Circulation. 2003;108:2666–2671
  52. Guazzi M, Agostoni PG, Guazzi MD. Alveolar-capillary gas exchange and exercise performance in heart failure. Am J Cardiol. 2001;88:452–457
  53. Ewert R, Wensel R, Bettmann M, Spiegelsberger S, Grauhan O, Hummel M, et al. Ventilatory and diffusion abnormalities in long-term survivors after orthotopic heart transplantation. Chest. 1999;115:1305–1311
  54. Mettauer B, Lampert E, Charloux A, Zhao OM, Epailly E, Oswald M, et al. Lung membrane diffusing capacity, heart failure, and heart transplantation. Am J Cardiol. 1999;83:62–67
  55. Guazzi M, Pontone G, Brambilla R, Agostoni P, Reina G. Alveolar-capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure. Eur Heart J. 2002;23:467–476
  56. Guazzi M, Agostoni P. Angiotensin converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane. Clin Sci. 1999;96:17–22
  57. Guazzi M, Pontone G, Agostoni P. Aspirin worsens exercise performance and pulmonary gas exchange in patients with heart failure who are taking angiotensin-converting enzyme inhibitors. Am Heart J. 1999;138:254–260
  58. Guazzi M, Melzi G, Agostoni P. Comparison of changes in respiratory function and exercise oxygen uptake with losartan versus enalapril in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1997;80:1572–1576
  59. Guazzi M, Agostoni P, Guazzi MD. Modulation of alveolar-capillary sodium handling as a mechanism of protection of gas transfer by enalapril and not by losartan, in chronic heart failure. J Am Coll Cardiol. 2001;37:398–406
  60. Bhoola KD, Figueras CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev. 1992;44:1–80
  61. Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev. 1995;47:25–49
  62. Guazzi M, Brambilla R, De Vita S, Guazzi MD. Diabetes worsens pulmonary diffusion in heart failure, and insulin counteracts this effect. Am J Respir Crit Care Med. 2002;166:978–982
  63. Dincer HE, Gangopadhyay N, Wang R, Bruce DU. Norepinephrine induces alveolar epithelial apoptosis mediated by alpha-, betha-, and angiotensin receptor activation. Am J Physiol. 2001;281:L624–L630
  64. Agostoni P, Magini A, Andreini D, Contini M, Apostolo A, Bussotti M, et al. Spironolactone improves lung diffusion in chronic heart failure. Eur Heart J. 2005;26:159–164
  65. Guazzi M, Agostoni PG, Matturri M, Pontone G, Guazzi MD. Pulmonary function, cardiac function and exercise capacity in a follow-up of congestive heart failure patients treated with carvedilol. Am Heart J. 1999;138:460–467
  66. Agostoni P, Contini M, Cattadori G, Apostolo A, Sciomer S, Bussotti M, et al. Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?. Eur J Heart Fail. 2007;9:827–833
  67. Snyder EM, Beck KC, Turner ST, Hoffman EA, Joyner MJ, Johnson BD. Genetic variation of the beta2-adrenergic receptor is associated with differences in lung fluid accumulation in humans. J Appl Physiol. 2007;102:2172–2178
  68. Snyder EM, Beck KC, Dietz NM, Joyner MJ, Turner ST, Johnson BD. Influence of beta2-adrenergic receptor genotype on airway function during exercise in healthy adults. Chest. 2006;129:762–770
  69. Galiè N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LY, Badesch D, et al. Sildenafil use in pulmonary arterial hypertension (SUPER) study group. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005;353:2148–2157
  70. Moraes DL, Colucci WS, Givertz MM. Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management. Circulation. 2000;102:1718–1723
  71. Stamler JS, Loh E, Roddy MA, Currie KE, Creager MA. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation. 1994;89:2035–2040
  72. Guazzi M, Tumminello G, Di Marco F, Fiorentini C, Guazzi MD. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. J Am Coll Cardiol. 2004;44:2339–2348
  73. Guazzi M, Samaja M, Arena R, Vicenzi M, Guazzi MD. Long-term use of sildenafil in the therapeutic management of heart failure. J Am Coll Cardiol. 2007;50:2136–2144
  74. Cooper BG, Taylor R, Alberti KGMM, Gibson GJ. Lung function in patients with diabetes mellitus. Respir Med. 1990;84:235–239
  75. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest. 1996;97:2601–2610
  76. Agostoni P, Marenzi G, Lauri G, Perego G, Schianni M, Sganzerla P, et al. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency. Failure of furosemide to provide the same result. Am J Med. 1994;96:191–196
  77. Agostoni P, Guazzi M, Bussotti M, Grazi M, Palermo P, Marenzi G. Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure. J Am Coll Cardiol. 2000;36:1600–1604
  78. Hambrecht R, Gielen S, Linke A, Fiehn E, Yu J, Walther C, et al. Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure. A randomised trial. JAMA. 2000;283:3095–3101
  79. Guazzi M, Reina G, Tumminello G, Guazzi MD. Improvement of alveolar-capillary membrane diffusing capacity with exercise training in chronic heart failure. J Appl Physiol. 2004;97:1866–1873
  80. Maiorana A, O'Driscoll G, Dembo L, Cheetham C, Goodman C, Taylor R, et al. Effect of aerobic and resistance exercise training on vascular function in heart failure. Am J Physiol Heart Circ Physiol. 2000;279:H1999–H2005

 This report was supported by the Monzino Foundation, Milano, Italy.

 No conflict of interest exists.

PII: S1071-9164(08)00179-6

doi: 10.1016/j.cardfail.2008.06.004

Journal of Cardiac Failure
Volume 14, Issue 8 , Pages 695-702 , October 2008

Article Tools

* Image Usage & Resolution